North America Biopharmaceuticals Market to Reach US$ 315 Billion by 2028
January 24, 2024 13:40 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis" report has been added to ResearchAndMarkets.com's offering.The North...
Regenerative Medicine Market Set to Surge with 25.36% CAGR, Projected to Reach US$122.381 Billion by 2028
January 24, 2024 13:00 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...
Soft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and Companies
January 24, 2024 12:02 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Soft Tissue Biologics Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update"...
Lyophilization Services for Biopharmaceuticals Market to Reach $2.45 Billion by 2027, Driven by Growing Biologics Demand
January 23, 2024 01:18 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services For Biopharmaceuticals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global...
Soft Tissue Biologics Market Forecast to 2033 – Detailed Analysis of Procedures, Regulatory Landscape, and Country-Specific Healthcare Insights
January 22, 2024 14:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Biopharmaceutical Industry Emerging Technologies, Trends and Macroeconomic Factors to Dominate in 2024: Cell and Gene Therapies will be the Key Focus in 2024
January 17, 2024 11:38 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition" report has been added to ResearchAndMarkets.com's offering.While the fight against COVID-19 is...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
January 09, 2024 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...
Microbiome Market Trends Report 2023: Emerging Therapeutics and Omics-based Research Spotlighting Global Progress
January 09, 2024 06:14 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. New research findings delve into the swiftly expanding...
MacroGenics to Participate in Upcoming Investor Conference
January 08, 2024 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Bioprocess Validation Market Analysis 2024-2033: Focused Insights on Test Types, End Users, and Regional Growth Forecasts through 2033
January 08, 2024 05:03 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033"...